Scarica l'app Stockscreener
141.35
1.68%
2.34
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché KRYS Giù?
Forum
Previsione
Krystal Biotech Inc Borsa (KRYS) Ultime notizie
Yousif Capital Management LLC Trims Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Abeona Therapeutics' Zevaskyn Vs. Krystal Biotech's Vyjuvek (KRYS, ABEO) - Seeking Alpha
Krystal Biotech (NASDAQ:KRYS) and VectivBio (NASDAQ:VECT) Critical Review - Defense World
Cantor Fitzgerald Estimates Krystal Biotech FY2026 Earnings - Defense World
Krystal Biotech at Goldman Sachs Conference: Strategic Insights on VYJEVEC - Investing.com Canada
Why Is Krystal Biotech (KRYS) Down 3.5% Since Last Earnings Report? - Yahoo Finance
Exploring Three High Growth Tech Stocks In The US Market - simplywall.st
H.C. Wainwright maintains Krystal Biotech stock Buy rating at ASCO 2025 - Investing.com Nigeria
Krystal Biotech to Present at Goldman Sachs 46th Annual Global Healthcare Conference - The Manila Times
How To Trade (KRYS) - news.stocktradersdaily.com
Krystal Biotech Reports Promising Results for KB707 Trial - TipRanks
Implied Volatility Surging for Krystal Biotech Stock Options - Yahoo Finance
Implied Volatility Surging For Krystal Biotech Stock Options - Barchart.com
Head-To-Head Analysis: Genocea Biosciences (NASDAQ:GNCAQ) vs. Krystal Biotech (NASDAQ:KRYS) - Defense World
Krystal Biotech Enters Oversold Territory (KRYS) - Nasdaq
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
Lazard Asset Management LLC Sells 922 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
D. E. Shaw & Co. Inc. Trims Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Why We're Not Concerned Yet About Krystal Biotech, Inc.'s (NASDAQ:KRYS) 26% Share Price Plunge - simplywall.st
Bank of America Corp DE Has $11.88 Million Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Krystal Biotech stock hits 52-week low at $127.33 By Investing.com - Investing.com South Africa
Krystal Biotech Holds Annual Stockholders Meeting - MSN
Krystal Biotech stock hits 52-week low at $127.33 - Investing.com
Krystal Biotech, Inc. (NASDAQ:KRYS) Position Cut by BNP Paribas Financial Markets - Defense World
Citigroup Lowers Krystal Biotech (NASDAQ:KRYS) Price Target to $155.00 - Defense World
Krystal Biotech (KRYS) Price Target Lowered by Citigroup | KRYS Stock News - GuruFocus
The Analyst Verdict: Krystal Biotech In The Eyes Of 12 Experts - Benzinga
Krystal Biotech (KRYS) Sees Price Target Cut Amid Sales Forecast Adjustment | KRYS Stock News - GuruFocus
H.C. Wainwright maintains Buy on Krystal Biotech shares By Investing.com - Investing.com Nigeria
Transcript : Krystal Biotech, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 11 - marketscreener.com
Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore - MarketBeat
Krystal Biotech's (NASDAQ:KRYS) Solid Earnings Have Been Accounted For Conservatively - Yahoo Finance
Krystal Biotech Expands Gene Therapy Platform - TipRanks
How the (KRYS) price action is used to our Advantage - news.stocktradersdaily.com
FY2025 EPS Estimates for Krystal Biotech Lowered by Analyst - Defense World
Cantor Fitzgerald Predicts Krystal Biotech FY2025 Earnings - Defense World
Q4 EPS Estimates for Krystal Biotech Lifted by HC Wainwright - Defense World
Biotech Alert: Searches spiking for these stocks today - Yahoo Finance
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today - Benzinga
Krystal Biotech, Inc. (KRYS): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Insider Monkey
10 Best Cancer Stocks to Invest in for Long-Term Gains - Insider Monkey
H.C. Wainwright maintains Buy on Krystal Biotech shares - Investing.com Australia
Krystal Biotech, Inc. (KRYS) Misses Q1 Earnings and Revenue Estimates - MSN
Krystal Biotech "insulated" by domestic manufacturingPittsburgh Business Times - The Business Journals
Krystal Biotech (KRYS) Price Target Lowered by Guggenheim | KRYS Stock News - GuruFocus
Krystal Biotech (KRYS) Faces Hurdles After Lowered Price Target - GuruFocus
Krystal Biotech (KRYS) Faces Hurdles After Lowered Price Target | KRYS Stock News - GuruFocus
Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2025 Earnings Call Transcript - Insider Monkey
Krystal Biotech to Present at BofA Securities 2025 Health Care Conference - The Manila Times
1.45%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):